Skip to main content
Clinical Trials/NCT02338882
NCT02338882CompletedPhase 4

Randomised Clinical Investigation of the Bi Flex M Multifocal Intraocular Lens

Dr Phillip J Buckhurst0 sites100 target enrollmentStarted: September 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
100
Primary Endpoint
Monocular Visual Acuity (VA)

Study Overview

Brief Summary

During cataract surgery an artificial lens is implanted in the eye. These artificial lenses are called intraocular lenses (IOLs) and there are many different types of IOL designs. IOLs are of fixed focus and so unless a multifocal IOL is used you would need to wear spectacles for viewing near objects. This study has been designed to look at how well a multifocal IOL corrects distance and near vision in comparison with a conventional monofocal IOL. Both types of IOLs are commercially available and are commonly implanted. Using new non-invasive methods we hope to be able to better judge the visual performance of these IOLs. In addition the study will involve imaging and examining the IOLs to determine the prevalence of any post-operative complications.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age related cataract patients requiring cataract surgery with phacoemulsification.
  • •Patients requiring primary IOL implantation
  • •Patients with a potential corrected visual acuity of 20/40 or better on clinical assessment
  • •Patients with normal anterior segments apart from cataracts
  • •Subjects with clear intraocular media other than cataract

Exclusion Criteria

  • •Preexisting pathology or physiology, which may be aggravated by the implant, or may render the implant ineffective and that could potentially cause future acuity losses to a level of 0.5 or 20/40 or worse in either eye. This includes the following:
  • •Microphthalmia
  • •Corneal decompensation or Endothelial Insufficiency
  • •Pseudo exfoliation
  • •High myopia
  • •Pars planitis
  • •Patient with greater than 1 dioptre of preoperative corneal astigmatism
  • •Subjects who are expected to require retinal laser treatment
  • •Previous intraocular and/or corneal surgery
  • •History of uveitis, glaucoma, proliferative diabetic retinopathy, pseudoexfoliation, macular degeneration that may affect potential best corrected visual acuity of 20/40 or better
  • •Operative complications of posterior capsular rupture, zonular dehiscence, incomplete continuous curvilinear capsulorhexis, severe iris /corneal trauma and inability to achieve secure placement in the designated location
  • •Subjects using a systemic medication that is known to cause ocular side effects
  • •Subjects participating in a concurrent clinical trial or if they have participated in an ophthalmology clinical trial within the last 30 days
  • •Subjects who have only one eye with potentially good vision
  • •Patients who are not willing to cooperate for the follow up period
  • •Visual eccentricity of greater than 0.7mm
  • •Pregnant women
  • •Patients where it is not possible to take informed consent

Arms & Interventions

Bi flex M multifocal intraocular lens

Experimental

Subjects implanted bilaterally with the Bi flex M multifocal intraocular lens

Intervention: Bi flex M multifocal intraocular lens (Device)

Bi flex 1.8 monofocal intraocular

Active Comparator

Subjects implanted bilaterally with the Bi flex 1.8 monofocal intraocular lens

Intervention: Bi flex 1.8 monofocal intraocular lens (Device)

Outcomes

Primary Outcomes

Monocular Visual Acuity (VA)

Time Frame: Visit 1 [3-6 months]

Monocular Visual acuity at 3-6 months assessed at distance intermediate and near both corrected and uncorrected. Assessed in LogMAR

Long Term Monocular Visual Acuity (VA)

Time Frame: Visit 2 [12-18 months]

Monocular Visual acuity at 12-18 months assessed at distance intermediate and near both corrected and uncorrected. Assessed in LogMAR

Binocular Visual Acuity (VA)

Time Frame: Visit 1 [3-6 months]

Binocular Visual acuity at 3-6 months assessed at distance intermediate and near both corrected and uncorrected. Assessed in LogMAR

Defocus Curve Profiles

Time Frame: visit 1 (3-6 months)

Visual acuity measurement (assessed in LogMAR) taken with differing levels of optical defocus

Long Term Defocus Curve Profiles

Time Frame: visit 2 (12-18 months)

Assessed as a dioptric range and using the Defocus area metric

Long Term Binocular Visual Acuity (VA)

Time Frame: Visit 2 [12-18 months]

Binocular Visual acuity at 12-18 months assessed at distance intermediate and near both corrected and uncorrected. Assessed in LogMAR

Secondary Outcomes

  • Long Term Monocular Pelli-Robson Contrast Sensitivity (CS)(Visit 2 [12-18 months])
  • Pelli-Robson Binocular Contrast Sensitivity(Visit 1 [3-6 months])
  • Long Term Reading Performance(Visit 2 (12-18 months))
  • Reading Performance(visit 1 (3-6 months))
  • Long Term Binocular Pelli-Robson Contrast Sensitivity (CS)(Visit 2 [12-18 month])
  • Pelli-Robson Monocular Contrast Sensitivity(Visit 1 [3-6 months])
  • Long Term Glare(Visit 2 (12-18 months))
  • Glare(visit 1 (3-6 months))
  • Long Term Contrast Sensitivity CSV-1000(Visit 2 [12-18 months])
  • Contrast Sensitivity CSV-1000(Visit 1 [3-6 months])

Investigators

Sponsor
Dr Phillip J Buckhurst
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Dr Phillip J Buckhurst

Associate Professor (Senior Lecturer)

University of Plymouth

Similar Trials